Podcasts about Overweight

Many patients believe that feeling hungry is simply part of losing weight, but it doesn't have to be. In this episode of our Avocados in Practice mini-series, sponsored by Avocados - Love One Today®, Patricia Bannan, MS, RDN, joins me to discuss why satiety matters, what the research says about fullness and foods and nutrients that influence it, and how clinicians can help patients build meals that are both satisfying and nutrient-dense. We also explore common misconceptions about higher-fat foods, practical nutrition strategies for patients taking GLP-1 medications, and simple ways to incorporate avocados into everyday meals to support fullness and satisfaction.What You'll LearnWhy hunger is one of the biggest barriers to sustainable weight lossThe role of satiety and meal satisfaction in weight managementWhat research tells us about avocados, weight, and body compositionWhy fiber and unsaturated fats  matter alongside protein, especially for patients eating less overallPractical ways to incorporate avocados for satisfying meals and snacksResources MentionedAvocados, GLP-1 and Weight Loss Medications: Making Every Bite CountAvocados and Satiety: A Deep Dive Into Fullness and Weight ManagementEffect of Incorporating 1 Avocado Per Day Versus Habitual Diet on Visceral Adiposity: A Randomized TrialUsing the Avocado to Test the Satiety Effects of a Fat-Fiber Combination in Place of Carbohydrate Energy in a Breakfast Meal in Overweight and Obese Men and Women: A Randomized Clinical TrialAbout Today's SponsorAvocados – Love One Today® is a leading source of the healthiest reasons and tastiest ways to enjoy fresh avocados. Backed by science, Love One Today provides turnkey solutions that make it easy for health professionals to stay on top of the latest research and confidently recommend fresh avocados to patients. Embracing the diversity of Latin flavors and traditions while promoting a healthier lifestyle, Aguacates - Love One Today® also offers culturally inspired recipes, tips, and educational handouts para Latinos. Visit LoveOneToday.com for free evidence-based resources, recipes and patient education materials.Any Questions? Send Me a MessageSupport the showConnect with Colleen:InstagramLinkedInSign up for my FREE Newsletter - Nutrition hot-topics delivered to your inbox each week.Disclaimer: This podcast is a collection of ideas, strategies, and opinions of the author(s). Its goal is to provide useful information on each of the topics shared within. It is not intended to provide medical, health, or professional consultation or to diagnosis-specific weight or feeding challenges. The author(s) advises the reader to always consult with appropriate health, medical, and professional consultants for support for individual children and family situations. The author(s) do not take responsibility for the personal or other risks, loss, or liability incurred as a direct or indirect consequence of the application or use of information provided. All opinions stated in this podcast are my own and do not reflect the opinions of my employer. 

Eugene talks about the large amount of money it takes to maintain an overweight male body in the United States. Find Eugene Trufkin Here ---------------------------------------------------- Join my weekly Facebook Lives: Facebook: Facebook Website: https://www.trufkinathletics.com/ Instagram: https://www.instagram.com/eugene_trufkin/?hl=en TikTok: https://www.tiktok.com/@eugenetrufkin Book - http://trufkin.link/affsg_yt Ready to make a change? Book a call @ https://trufkinathletics.com/connect

Nutrition Nugget! Bite-sized bonus episodes offer tips, tricks and approachable science. This week, Jenn is talking about Retatrutide, the third-generation injectable making waves as the most powerful weight-loss drug studied yet. It targets three hormone pathways at once instead of just one or two, and early trial participants have lost staggering amounts of weight, some over 30 percent of their body weight. But is more always better? Jenn breaks down how this triple mechanism works in the body, what the research shows so far, and why it might finally help the roughly 10 percent of people who never responded to earlier GLP-1s. Still, she has been raising the same concerns since Ozempic first came onto the scene, and this new drug is no exception. Is Retatrutide the breakthrough the weight loss world has been waiting for, or just a stronger version of the same unanswered questions? Tune in to hear Jenn's full take. Like what you're hearing? Be sure to check out the full-length episodes of new releases every Wednesday. Have an idea for a nutrition nugget? Submit it here: https://asaladwithasideoffries.com/index.php/contact/ RESOURCES:Become a Happy Healthy Hub MemberJenn's Free Menu PlanA Salad With a Side of FriesA Salad With A Side Of Fries MerchA Salad With a Side of Fries InstagramOzempicAmerican Diabetes Association Retatrutide—A Game Changer in Obesity Pharmacotherapy - PMCGlucagon | HormonesInternational Journal of Molecular SciencesHyperglycemia vs. Hypoglycemia: Differences in Causes and Symptoms - GoodRxGlucagon Control on Food Intake and Energy Balance - PMCLilly Phase 3 StudyComparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials - ScienceDirectLilly - RetatrutideWhat Is Osteoarthritis? Causes, Symptoms, and Treatments - GoodRxPotential Retatrutide Benefits You Should Know About - GoodRxClinical TrialsStudy Details | NCT07165028 | A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) | ClinicalTrials.govClinical TrialsStudy Details | NCT06383390 | The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)ClinicalTrials.govClinical TrialsNCT07035093 | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain | ClinicalTrials.gov11 GLP-1 Side Effects You Should Know About - GoodRxTriple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial | New England Journal of Medicine Counterfeit DrugsPeptides for Weight Loss: What They Are and How They Work - GoodRxJenn Trepeck, Nutrition Nugget, Salad With A Side Of Fries, Health Tips, Wellness Tips, Retatrutide, Glp 1, Gip, Glucagon, Weight Loss, Ozempic, Wegovy, Mounjaro, Zepbound, Tirzepatide, Semaglutide, Insulin Sensitivity, Gastric Emptying, Appetite Suppression, Blood Sugar Control, A1c, Glycated Hemoglobin, Liver Steatosis, Fatty Liver Disease, Diabetic Kidney Disease, Type 2 Diabetes, Metabolic Dysfunction, Cardiovascular Risk, Osteoarthritis, Bone Density, Muscle Loss, Body Composition, Clinical Trials, Phase Three Trials, Injectable Medication, Weight Loss Drug, Pharmaceutical Intervention, Hunger Hormone, Satiety, Nausea, Constipation, Gastrointestinal Side Effects, Compounding Pharmacy, Counterfeit Medication, Obesity Treatment, Incretin Hormone, Retatrutide Weight Loss Results, Third Generation Glp 1 Medication

For more coverage on the issues that matter to you, download the WMAL app, visit WMAL.com or tune in live on WMAL-FM 105.9 from 9:00am-12:00pm Monday-Friday  To join the conversation, check us out on Twitter @WMAL and @ChrisPlanteShow Learn more about your ad choices. Visit podcastchoices.com/adchoices

If I were over 50 and needed to lose 30 pounds, I'd focus on rebuilding the metabolic signals that change with age instead of simply eating less and exercising more. I'm breaking down how protein, smarter carbs, meal timing, strength training, sleep, stress, gut health, and natural GLP-1 signaling can work together to reduce stubborn belly fat and support sustainable weight loss after 50.GET A CUSTOMIZED WEIGHT LOSS PLAN:Have a free 1-on-1 call with our Expert Nutritionists

Die Wall Street schlittert den vierten Tag in Folge bergab. Die Renditen der US-Staatsanleihen schießen nach oben, einhergehend mit den Ölpreisen. Das Volumen der angekündigten Treasury-Rückkäufe enttäuscht einige Anleger. Gleichzeitig schürt Trumps Versprechen, bei einem republikanischen Wahlsieg jedem erwachsenen US-Bürger 5.000 US-Dollar auszuzahlen, zusätzliche Defizitsorgen. Die heutigen Erzeugerpreise und morgigen Verbraucherpreise finden viel Beachtung. Bei Apple fällt die Bilanz der Produktpräsentation überwiegend erwartungsgemäß aus. Das faltbare iPhone Duo startet bei 1.999 US-Dollar, die Pro-Modelle werden jeweils 100 US-Dollar teurer. Damit liegen die Preise am unteren Ende dessen, was manche Anleger erwartet hatten. Im KI-Sektor liefert Taiwan Semiconductor mit 53,3 Prozent Umsatzwachstum im August ein weiteres starkes Nachfragesignal. Meta erhält Rückenwind von JPMorgan. Die Bank stuft die Aktie auf „Overweight“ hoch und erhöht das Kursziel von 640 auf 820 US-Dollar, gestützt auf neue KI-Produkte und zusätzliche Erlösmöglichkeiten. Oppenheimer bleibt dagegen skeptisch, ob der neue KI-Agent Muse genügend zahlende Kunden gewinnen kann. Nach Börsenschluss berichten Oracle und Adobe. Besonders bei Oracle stehen neben dem Cloud-Wachstum die Finanzierung der gewaltigen KI-Investitionen und die erwarteten Mittelabflüsse im Mittelpunkt. Ein Podcast - featured by Handelsblatt. ► Jetzt beim Börsenspiel Trader mitmachen und Range Rover Evoque gewinnen: https://sg-zerti.de/wall-street-podcast ► Entdecke den exklusiven NordVPN Deal! Jetzt risikofrei testen mit einer 30-Tage-Geld-zurück-Garantie: https://nordvpn.com/wallstreet * +++ Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/wallstreet_podcast +++ ► Meine Trades. Direkter Austausch.

He was on the living room floor playing with his six-year-old son.When he tried to get up, he could not do it easily. A former rugby player. A national-level rugby coach. A man who had always been active his whole life. And in that moment he thought this is not right.Guy Gibson is 42 years old. He works two weeks on and two weeks off on oil rigs in Aberdeen. He had tried to sort things himself for years. He kept going round in circles.Then he lost 15 kilos, ran his first half marathon, and booked a cycling race in Mallorca.In this episode Guy sits down with me for a completely unscripted, raw and honest client hot seat covering everything. The moment on the floor. The back pain. The snapping at the people he loved most. The night shifts. The rugby career that defined him and then ended. And the journey that changed everything.We talk about:Why stepping away from playing rugby left a gap he never expected.How his weight and mood were quietly affecting everyone around him.What he tried before and why it kept failing. What finally made him reach out and what shocked him about the process. How he lost 12 kilos working night shifts and two week oil rig rotations.What the half marathon finish line felt like and what Mallorca means to him now.If you have ever been the fit one, the sporty one, the active one and then looked up one day and thought how did I get here, this episode is going to hit differently.

In the latest Global Market Outlook release, Hannah and Manpreet discuss the implications of today's bond yields for fixed income and equity portfolio positioning. They also explore how gold is benefiting from the current environment, supporting the reinstatement of our Overweight stance on the precious metal.You can read our latest Weekly Market View today here.Speaker(s):- Manpreet Gill, Chief Investment Officer, EMEA, Standard Chartered Bank - Hannah Chew, Portfolio Strategist, Standard Chartered Bank For more of our latest market insights, visit Market views on-the-go or subscribe to Standard Chartered Wealth Insights on YouTube.

This week, Darin and John are watching Eddie Murphy’s The Nutty Professor, with guest Nigel Fullerton of the Murphy Monday podcast! Overweight scientist Sherman Klump [...]

Die Wall Street startet nahezu unverändert in den Tag. Die PCE-Preisinflation für Juli hat die Erwartungen im Wesentlichen getroffen und liefert damit zunächst keinen neuen Inflationsschock. Damit kann sich der Fokus unmittelbar auf Nvidia verlagern, die heute nach Börsenschluss Zahlen melden. Die Erwartungen sind hoch. JP Morgan rechnet mit einem Beat-and-Raise-Quartal, sieht den Umsatz bei 94 bis 95 Milliarden US-Dollar und den neuen Ausblick bei 107 bis 108 Milliarden US-Dollar. Gleichzeitig ist die Stimmung zuletzt deutlich optimistischer geworden und Short-Positionen wurden zurückgefahren mit einer entsprechend hohen Messlatte. Der Optionsmarkt preist eine Bewegung von rund 4,6 Prozent ein. Für Entspannung sorgt der Ölpreis. Brent fällt um rund drei Prozent auf etwa 86 US-Dollar, nachdem Iran und Oman Fortschritte bei einer Vereinbarung zur Öffnung der Straße von Hormus signalisiert haben. Gleichzeitig bleibt Software unter Druck. Intuit enttäuschte mit dem Umsatzausblick, und Analysten reagieren drastisch: JP Morgan stuft die Aktie von „Overweight“ auf „Neutral“ ab und kappt das Kursziel von 605 auf 331 US-Dollar. Die Bank warnt, dass sich die Risiken durch KI-Disruption inzwischen von TurboTax auf QuickBooks ausweiten. Im Einzelhandel fallen die Zahlen uneinheitlich aus. Wirklich beeindruckende Zahlen und Aussichten meldet Abercrombie, mit der Aktie entsprechend fest. Bath & Bodyworks senkt bei genauer Betrachtung die Ertragsaussichten. Bei Kohl's enttäuschen die vergleichbaren Umsätze, und es sind vor allem Zollerstattungen, die den Ertrag angefacht haben. Ein Podcast - featured by Handelsblatt. ► Jetzt beim Börsenspiel Trader mitmachen und Range Rover Evoque gewinnen: https://sg-zerti.de/wall-street-podcast ► Entdecke den exklusiven NordVPN Deal! Jetzt risikofrei testen mit einer 30-Tage-Geld-zurück-Garantie: https://nordvpn.com/wallstreet * ► Erhalte einen exklusiven 15% Rabatt auf Saily eSIM Datentarife! Lade die Saily-App herunter und benutze den Code wallstreet beim Bezahlen: https://saily.com/wallstreet * +++ Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/wallstreet_podcast +++ ► Mehr Einblicke: https://bit.ly/360wallstreetpc * Impressum: https://www.360wallstreet.de/impressum *Werbung

☎️ Book Your COACHING INQUIRY Call: https://calendly.com/d/386-k9q-4cg/coaching-inquiry-call-zoom☎️ Book Your COMPLEMENTARY CONSULTATION and CALORIE CALCULATION Call: https://calendly.com/d/2p8-mxx-dgf/free-consultation-call-zoom⁠⁠⁠⁠⁠⁠In this episode, I tackle the biggest reasons intuitive eating backfires for women in peri and postmenopause. Honoring your hunger cues can be one of the biggest mistakes you ever make. Why would you honor your hunger cues if you don't think that your body is responding correctly to food, to training, to all your fat loss efforts? What makes you assume that it's sending you accurate hunger signals? After tuning into this episode, you are going to understand:➤ what the four biggest factors are that are causing your intuitive eating to backfire➤ the role your hormones play once you hit 40➤ how to actually improve your natural hunger cues➤ Exactly how to eat and what to eat So you can get the results you deserve.Links mentioned in the episode: ➤ When More Protein Makes You Fat In Menopause (Gluconeogenesis) | MMP Ep. 301: https://youtu.be/WqmzEHghfGQ➤ Fiber Guide: https://www.vitalityoet.com/fiber➤ You Sleep But Feel Exhausted: 6 Steps To Get Energy Back In Perimenopause & Menopause | MMP Ep. 284: https://youtu.be/X__ual4S8o4

Why a “Normal” BMI May Not Be Healthy After 65 | The Truth About BMI in Older Adults If you're over 65, the BMI chart you've been using your entire life may not tell the whole story. We've all been taught that a “normal” BMI falls between 18.5 and 24.9. But when it comes to older adults, research tells a different story. In fact, a BMI between approximately 23.0 and 29.9 may be associated with better outcomes for many adults over 65. So why does the healthy BMI range appear to shift as we age? In this episode, I break down the research behind BMI in older adults and explain why being classified as “overweight” on a standard BMI chart does not necessarily mean an older adult should lose weight. We discuss the importance of nutritional reserves, muscle mass, frailty, unintentional weight loss, falls, recovery from illness, and why looking at the number on the scale alone can be misleading. Whether you're an older adult, caring for an aging parent, or a dietitian working with older adults, this episode will help you better understand how BMI should be interpreted later in life. If you found this episode helpful, please subscribe and share it with someone who cares for older adults, works in clinical nutrition, or has questions about healthy weight and aging. I'm Michelle Saari, MS, RD, a dietitian specializing in geriatric nutrition and helping dietitians better care for older adults. Here, we talk about the practical side of nutrition, aging, long-term care, and clinical nutrition so you can feel more confident supporting older adults.

Marine Corps Sergeant Major Jean-Paul Corville served 22 years in the United States Marine Corps from 1991 to 2013, earning the Bronze Star with Valor and rising to the rank of Sergeant Major.In this episode of Urban Valor, Corville shares Marine Corps boot camp stories, infantry life, combat in Iraq, leadership lessons, disaster response in Japan, and the decision that ultimately changed the course of his career.He talks about growing up shy and overweight in Louisiana, transforming himself through training, choosing the Marines, becoming an 0331 machine gunner, serving at 29 Palms, deploying to Okinawa, becoming a drill instructor, and eventually reaching the highest enlisted levels of Marine Corps leadership.Corville also opens up about combat, loss, mistakes, consequences, and what happened when one decision cost him more than he ever expected.From hilarious Marine Corps stories to some of the darkest moments of his life, this is an unfiltered look at a 22-year military career from someone who lived it at every level.

Sunna van Kampen, founder of Tonic Health, joins Tim Gray to reveal what is really hiding in your supermarket trolley, from fish fingers that are less than half fish to white chocolate that is no longer chocolate, and why he believes fixing the nation's health starts with what you put in your basket, not with biohacking.

In this episode of Brett's ManCave, I get real about the dangers of letting family problems, personal health, and everyday stress pile up until you feel like you're carrying the weight of the world—literally and figuratively. I talk about how stress can affect your health, your mindset, and your overall life, while taking a brutally honest look at my own struggles with being overweight. And because apparently talking about health wasn't uncomfortable enough, I take you on a trip down memory lane to my Disneyland horror stories, where the happiest place on Earth became a terrifying battle against amusement-park seats. From struggling to fit on rides to wondering if I was about to become the attraction, I share the embarrassing, hilarious, and painfully real moments that made me realize it was time to take a serious look at myself. This episode is about stress, family, health, self-awareness, and learning to laugh at yourself while facing some hard truths. Sometimes the biggest wake-up call comes when you're sitting in a Disneyland ride trying to figure out whether the ride is going to start—or whether you're going to have to be rescued first. 

With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast: The Points of CARE, the official podcast of Diabetes, Obesity, and CardioMetabolic CARE. Join hosts Richard Beaser, MD and Jane Reusch, MD, as they highlight key research findings, clinical implications, and emerging themes across diabetes, obesity, and cardiometabolic health through interviews with journal authors and subject-matter experts. 1:15 Our hosts speak with Katherine R. Tuttle, MD, FASN, FACP, FNKF, Executive Director of Research at Providence Inland Northwest Health and a Professor of Medicine at the University of Washington School of Medicine. She is an author of the article "SGLT2 Inhibitors for the Primary Prevention of CKD in Type 2 Diabetes: A Systematic Review and Meta-analysis," available at doi.org/10.2337/doci26-0001. 8:50 Next, Richard introduces Alexander Turchin, MD, MS, Director of Informatics Research at the Division of Endocrinology at Brigham and Women's Hospital and Associate Professor of Medicine at Harvard Medical School. He is an author of "Trends in Diabetes Medications After Metformin in Patients at High Versus Moderate Cardiovascular Risk: The BESTMED Consortium 2014–2022," available for free at doi.org/10.2337/doc26-0027. 17:05 Richard and Jane highlight special material available in the latest issue of Diabetes, Obesity, and CardioMetabolic CARE. "Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults: Standards of Care in Overweight and Obesity—2026," available for free at doi.org/10.2337/doci26-0003 "Employment and Diabetes: A Statement of the American Diabetes Association," available for free at doi.org/10.2337/doc25-0092. 23:40 Finally, Richard and Jane highlight some of their favorite articles from the July-August issue. Vidovic, et al. Behavior Modifications From CUT-DM, Including Lifestyle Modification and Self-Efficacy doi.org/10.2337/doc25-0093 Chan, et al. Pharmacist-Driven Pre-Visit Planning to Optimize Prescribing in Type 2 Diabetes doi.org/10.2337/doc26-0019 Bannuru, et al. RAAS Inhibitors for the Primary Prevention of CKD in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-analysis doi.org/10.2337/doci25-0014 Dimentstein, et al. Goals of Care Among Caregivers of Youths With Type 1 Diabetes doi.org/10.2337/doc26-0035 To learn more about Diabetes, Obesity, and CardioMetabolic CARE please visit diabetesjournals.org/docm-care. Thank you for listening, and don't forget to subscribe.

If you're ready to get real then listen in now: the topic is food complaint, overweight blame, and the gap between Victimville and Freedomland. You CAN stop binge eating, stop emotional eating, and kick yo-yo dieting for good, but it will require a move if you're currently stuck. Mindset is 92.8% of the solution. Shift your mind to lose weight for good. Let's Get Real: Food Complaints and Overweight Blame [Podcast #710] Original copyrighted content published May 28, 2026 at https://fearlessfatloss.com/podcast/lets-get-real-food-complaints-and-overweight-blame © 2026-Present JoLynn Braley International LLC

A mom writes in: her 10-year-old daughter compared weights with classmates and now says she's "so fat," though she's at a perfectly healthy weight. In this episode, Elizabeth Urbanowicz offers a biblical way to help a child struggling with body image, showing why simply boosting self-esteem falls short and how to get to the real root. She then widens the lens to comparison and coveting in any area of a child's life, from weight to talents to belongings, and walks through how to repent of comparison and replace it with genuine gratitude.

Most apple cider vinegar on supermarket shelves is dead. Pasteurized. Filtered. Stripped of the mother, the enzymes, and the polyphenols that made vinegar a medical remedy for over 2,000 years — sold back to you at a 33-fold markup for what's essentially acidified water. In this episode, we make genuine raw, unpasteurized apple cider vinegar from scratch — for about 30 cents a batch. You'll learn the two-stage fermentation process, how to avoid mold and spoilage, and why homemade ACV is more biologically active than anything you can buy. ⏱ Cost breakdown: $10 vs $0.30 11:00 — Safety rules you must follow

In this deep-dive listen, Ray Heung and Manpreet Gill break down where we see value in current markets. Tune in as they outline why we remain constructive on risk assets overall, why we maintain an Overweight stance on equities and what drove our decision to move bonds back to a Neutral/Core holding within our asset allocation. This episode also covers our downgrade of gold from Overweight to a Neutral/Core holding.You can read our latest Global Market Outlook today here.Speaker(s):- Manpreet Gill, CIO of Africa, Middle East & Europe (AME/E), Standard Chartered Bank - Ray Heung, Senior Investment Strategist, Standard Chartered BankFor more of our latest market insights, visit Market views on-the-go or subscribe to Standard Chartered Wealth Insights on YouTube.

On his deathbed, Keith Titus told his son: "You're not welcome at Page. I have a plan, and you're not part of it." Three years later, the plan had failed. The company was down from 230 trucks to 70, losing a million dollars a year, and the bank had cut them off. Then Dan's mom — a 27-year school bus driver who never worked a day in the business — made a decision that changed everything: she put every dollar of her husband's life insurance into the company. "I grew up on a dirt-poor farm. I've got no problem going back there." In this episode, Dan Titus of Page Trucking sits down with us in upstate New York to share one of the most incredible comeback stories in bulk freight: five generations on the Titus family farm, a trucking company started in 1974 with $5,000 from his great-grandfather, losing his dad and grandfather a year apart, and rebuilding Page into 500 trucks, 900 trailers, and 650 families — hauling everything from grain to hazardous waste to 1,400° molten metal down the highway. Oh, and they heat their warehouses with Bitcoin miners. ⏱️ CHAPTERS 00:00 Outgrowing the building (again) 01:56 Five generations on the Titus farm — Cato, NY, since 1809 02:32 Dad starts brokering freight without Grandpa knowing 05:28 $5,000 from Great-Grandpa to start a trucking company 06:00 Why it's called "Page" — the $250 authority 08:07 Why his dad chose trucking over farming 13:24 "You're not welcome at Page" — his dad's dying plan 15:21 Mom inherits a collapsing business 21:05 Betting the life insurance money on the company 22:37 Half the pay, twice the hours — Dan comes home 25:45 Buying the business back from Mom 26:40 Teamsters, a $3M pension liability & near-bankruptcy 29:00 From 230 trucks… to 70… to 500 today 32:37 Closed-loop hauling: scrap, dross & aluminum 34:27 Hauling 1,400° molten metal on the highway 38:24 Overweight permits & custom trailer designs 43:40 The Goulet Trucking acquisition 51:42 Why waste hauling is huge in the Northeast 56:22 Heating warehouses with Bitcoin miners 01:04:18 Keith Titus — the next generation 01:09:45 No handouts: earning your way into the family business 01:14:25 The chip on his shoulder — out-innovating $20B competitors 01:20:38 "I'm not ready" — why Page will never sell 01:24:13 Raising sharks, not minnows ABOUT BULKLOADS We started 15 years ago connecting bulk carriers with shippers and brokers in the ag and bulk industry — and today we're much more than a load board. Our mission is simple: serve this industry, support small businesses and trucking families, and help them succeed.

¿Has escuchado maravillas sobre medicamentos como Ozempic, Wegovy o Mounjaro, pero nadie te habla de las constantes náuseas y el malestar estomacal? La realidad clínica es que una gran parte de los pacientes abandonan estos tratamientos para la obesidad simplemente porque los efectos secundarios arruinan su calidad de vida. Pero la ciencia médica está a punto de dar un salto monumental. En este episodio, descubriremos a la AMILINA, una hormona producida por tu páncreas que está demostrando resultados asombrosos en ensayos clínicos: pérdida de peso significativa sin los severos vómitos ni malestares intestinales de los fármacos actuales. En este episodio aprenderás: → Cómo tu páncreas libera dos hormonas cada vez que comes. → Cómo la amilina bloquea el freno metabólico que hace que recuperes el peso perdido. → Cómo dos equipos de investigadores resolvieron el mismo problema químico de formas distintas. → Cómo la combinación CagriSema alcanza una reducción significativa del peso corporal. → Por qué la amilina resensibiliza tu cerebro a la leptina, algo que la semaglutida no logra.   Mi nombre es Dr. Mauricio González, médico internista y especialista en endocrinología en formación. Aquí comparto información basada en evidencia para que tomes decisiones de salud sin mitos ni marketing engañoso. Suscríbete a mi boletín informativo en: www.drmauriciogonzalez.com/   ⚠️ Este podcast tiene fines exclusivamente educativos e informativos y no constituye asesoramiento médico, diagnóstico ni tratamiento personalizado. Los medicamentos que se discuten en este episodio se encuentran en fase de investigación y no cuentan con aprobación de la FDA. Consulta siempre a tu médico o a un profesional de la salud calificado antes de cambiar tu régimen de tratamiento.   ¡Sigamos la conversación en redes sociales! Instagram

As current understandings of obesity (ie, a chronic disease requiring long-term management) are adopted across the world, screening and treatment can no longer follow a one-size-fits-all approach. Listen in as 3 global experts in obesity medicine highlight the emerging evidence from recent conferences that are changing real-world practice today. Learn how the latest findings apply to specific patient populations across the United States, Europe, and Asia as well as why healthcare professionals should individualize treatment based on patient preferences and relevant risk factors. Presenters: Stephano Del Prato, MD Professor Emeritus of Endocrinology University of Pisa Pisa, Italy Soo Lim, MD, PhD Professor of Medicine Department of Internal Medicine Seoul National University College of Medicine and Seoul National University Bundang Hospital Seoul, South Korea Donna H. Ryan, MD Professor Emerita Pennington Biomedical Research Center Louisiana State University New Orleans, Louisiana Link to full program:https://bit.ly/4pwFhEo Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Technology has significantly changed the world we live in. One of the areas it's changed is sporting events. Back in the day, we watched teams battle it out on weary-looking grass under incandescent flimsy filament bulbs on pixelated screens with clunky rotary knobs. Overweight and out of shape, umpires and referees were forced to make split-second decisions with no backup, inevitably leading to the cheers of fans positively impacted and the boos of fans who felt ill-treated!Today, we have instant replay scrubbing every angle of every play, reviewed on LED screens by officials stopping the game to review the action and make the absolutely correct call. Guess what, even with the latest and greatest tech, we sit back and question every call made in light of which team we prefer. He was out! That goal counted! Foul! NO FOUL!In this message, we continue our journey through the Exodus account, looking at the Red Sea. God's victory over the enemy is decisive, final, and resolute! No questions should remain, but somehow they persist! This weekend, we will be reminded of the powerful Savior, JESUS CHRIST, who is more than able to set us free from bondage and lead us into new life, with no room to question the result.Pastor Matt McCarter

Welcome to Season 6 of the Metalcore & Muscle Podcast! In this tenth episode of season six, we will be discussing the following topics: Boundaries Upcoming Album: In this segment we discuss the upcoming release from Boundaries and how the singles have sounded so far. We dive into where we think the newest album will fit into their discography. Coaches Corner: This segment continues from season 5 of the pod, where Evan discusses a fitness topic in depth and provides his health coaching insight. For this week, Evan discusses the question, is being overweight a choice? This was a question pulled from a YouTube video where fitness influencers were debating this question. Evan weighs in and provides a public health perspective on this question. Song of the Week: In this segment, we share/highlight a new song recently released and provide some general commentary. This week's song of the week is "Better or Not" by Paloma. Follow us on Instagram @mc_muscle! 

Coming up, Wegovy weight loss pills are now available in pharmacies and online in the UK. Will they help tackle obesity? Plus, how scientists are trying to restore sensation in the feet; the legacy of Dolly the sheep 30 years on; and space rovers and the solar eclipse with the astronomer Megan Argo. Like this podcast? Please help us by supporting the Naked Scientists

The  Moose on The Loose helps Canadians to invest with more conviction so they can enjoy their retirement. Today, we talk about the dilemma of paying capital gains taxes on a big position or holding it to avoid paying taxes. It's all about Dividend growth investing! Subscribe to the best free dividend investing newsletter: https://thedividendguyblog.com/newsletter Get the 20 income products guide for retirees: https://retirementloop.ca/income/

For years, Andy felt stuck.Overweight, frustrated, constantly weighing himself, and repeatedly returning to keto, he believed he just needed more discipline and more effort.So he worked harder.He tracked more.He exercised 6 days per week.And yet the results never seemed to last.In this powerful conversation, Andy shares how he broke free from the all-or-nothing mindset, learned to trust the small steps, and finally created a sustainable approach that led to big weight loss success! Whether you're a man struggling to get started . . .Or someone who's tired of starting over . . . This episode is packed with practical wisdom and insights that will help you find the success you want. We'll explore:What Andy wishes he knew years agoWhy keto seemed to work (until it didn't)How scale obsession was affecting his mindset Why working out more wasn't solving the problemHow he now approaches vacations without regaining weightWhat sustainable weight loss actually looks like in real life!While this conversation is especially valuable for men over 40, the principles Andy shares apply to anyone who's tired of chasing quick fixes and ready to build lasting results.Join Corey's Email Newsletter: https://LoseFatList.comANTI-DIET CLASS: https://AntiDietClass.com

Carl Quintanilla, Jim Cramer and David Faber covered a busy hour on the tech front: David reports Amazon plans to raise $25 billion in a bond sale according to sources; Chip stocks under pressure despite Samsung's record quarterly results; Several Wall Street analysts initiate coverage of SpaceX with "Buy" or "Overweight" ratings — as the stock makes its debut on the Nasdaq 100. Also in focus: A fresh record high for the Dow, oil prices rise on reports tankers were attacked in the Strait of Hormuz, President Trump in Turkey at the NATO summit, Walmart announces price cuts on thousands of items, Cramer on the consumer names he says are worth buying now, Nvidia and Apple battle for title of most valuable company.   Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

It's In the News - a look at the top diabetes headlines and stories happening now. Our top stories: More information about type 1 and COVID, including the vaccine, why is the latest GLP-1 medication, not yet FDA approved, showing up all over the place, what table sugar and vinegar could mean for drug costs, a new inhaled insulin study and much more  I'll see you at Friends for Life next week. Come find me at Table T18 Learn more about our in-person events here: https://diabetes-connections.com/events/ Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Transcript & links:    Okay.. our top story this week: XX A large Swedish study found that the increased risk of being diagnosed with type 1 diabetes after COVID-19 infection is mostly limited to the first 30 days after infection and does not continue long term. Researchers followed nearly the entire Swedish population under age 80 from 2020 through 2023 and found that while SARS-CoV-2 infection was linked to a temporary rise in new type 1 diabetes diagnoses, the risk declined over time. The study also found no evidence that COVID-19 vaccination increases the long-term risk of developing type 1 diabetes. Vaccination did not significantly change the relationship between COVID-19 infection and diabetes risk, and any small increase in diagnoses seen among adults shortly after a first vaccine dose was not seen after later doses or during longer follow-up. The researchers concluded that their findings do not support changing current COVID-19 vaccination recommendations because of concerns about type 1 diabetes risk. https://www.infectiousdiseaseadvisor.com/news/covid19-infection-may-increase-short-term-type-1-diabetes-risk/ XX Two new studies are challenging the traditional view that type 1 diabetes develops solely because the immune system attacks insulin-producing beta cells. Researchers from Indiana University found evidence that beta cells themselves may play an active role in determining whether they survive or succumb to the stresses that lead to type 1 diabetes. In the first study, scientists discovered that some healthy human beta cells can quickly activate an antiviral defense system when exposed to interferon-alpha, an immune signal often produced during viral infections. This response relies on molecules called reactive oxygen species (ROS), which are usually associated with cell damage but, in this case, appeared to help switch on protective antiviral genes. Researchers found this defense program in healthy cells and in people at risk for type 1 diabetes, but not in beta cells from people who already had the disease. The findings suggest that losing this built-in defense mechanism may make beta cells more vulnerable during the development of type 1 diabetes. The second study focused on autophagy, the process cells use to recycle damaged or worn-out components. Using a new imaging technique, researchers observed that beta cells in a mouse model of type 1 diabetes showed defects in autophagy before blood sugar levels began to rise and even before a full immune attack was underway. This suggests that problems inside the beta cells may occur early in the disease process rather than being caused entirely by the immune system. Together, the studies point to a more complex picture of type 1 diabetes. While they do not show that beta-cell defects cause the disease, they suggest that differences in how beta cells respond to stress, viral signals, and cellular damage may influence who develops type 1 diabetes and how the disease progresses. https://medicalxpress.com/news/2026-06-beta-cells-players-diabetes.html XX Researchers have created the most detailed map yet of how the human pancreas develops during childhood, offering new clues about why children are especially vulnerable to developing diabetes. The study, published in Nature Communications, examined pancreatic tissue from 123 children without diabetes, ranging from newborns through age 10. Using advanced imaging techniques, scientists tracked how insulin-producing islet cells grow and mature during the first decade of life. The researchers found that pancreas size varies dramatically at birth, with some infants having pancreases nearly four times larger than others. They also discovered that insulin-producing beta cells grow more slowly after birth than previously thought, suggesting that much of a person's lifelong beta cell capacity may be established before birth and during early childhood. Other findings showed that insulin-producing cells mature earlier than glucagon-producing cells and that new hormone-producing cells may continue to form after birth. The researchers hope this new understanding of pancreas development will help scientists identify diabetes risk earlier and develop better strategies for prevention and treatment in children. https://news.vumc.org/2026/06/29/unlocking-diabetes-secrets-pediatric-organ-donors-help-map-a-path-to-a-cure-and-prevention/   XX At the American Diabetes Association annual meeting, 2-year results from the SUPPRESS-EARLY trial showed that initiating tirzepatide (Mounjaro, Zepbound) early in the course of type 2 diabetes led to substantially higher rates of near-normal glycemic control and also led to broader metabolic improvements compared with intensive conventional therapy.   In this MedPage Today video, investigator Stefano Del Prato, MD, of the University of Pisa in Italy, discusses the findings.     Following is a transcript of his remarks:   What happened is that in the tirzepatide-treated arm, 85% of the population at the end of the second year was on the maximum dose of tirzepatide 15 mg. And then the remaining 15 with the different doses.   Interestingly, in the population that had been treated with the intensive conventional approach, 85% of them ended up to have, on top of metformin, a GLP-1 receptor agonist, mainly represented by subcutaneous semaglutide [Ozempic, Wegovy], 60+%, another 15% on oral semaglutide [Rybelsus], and the remaining on dulaglutide [Trulicity].   And I have to say that maybe the recommendation to really push along the line to try to achieve and to strive to achieve [glycemic] control was successful in these individuals. Because the population that had been recruited in the study started off with a baseline A1C of 7.8% and it went down to 6.3% in the conventionally intensive treatment, which is not bad at all, on average is below the target of 6.5%.     However, when we look at the effect of tirzepatide, the final level of A1C at the end of the second year was 5.6%, which is on average below the upper limit of the normal range for A1C, 5.7%. This also translates into more people not only achieving normal glycemia, if we can define normal glycemia as A1C below 5.7%, greater than what we observed in conventionally treated individuals. So it was around three times more people achieving an A1C of 5.7%, in the range of around 65%, as compared to 28% with people on a conventional optimized treatment.   Now, this is not surprising knowing the potency of tirzepatide. But again, going back to the rationale of the design, can we change what is the natural history of the disease? This seems to be at least of interest and it's possibly changing the trajectory of the disease for glycemic control, as I mentioned, but also in terms of the body weight and waist circumference because both body weight and waist circumference went much lower with tirzepatide compared to the conventional treatment.   Tirzepatide also was associated with an improvement in the lipid profile, in particular with the LDL, triglycerides, and the triglyceride concentration and non-HDL cholesterol, and also with a statistically significantly lower systolic blood pressure with a numerical reduction in the diastolic blood pressure.   And also the other thing that probably will ... become more apparent with the study continuing is that the investigators were allowed to add on any other treatment ... needed to achieve their target. So tirzepatide was just metformin and tirzepatide. In the control group, there was already 10% of people who were receiving two drugs on top of the metformin.   So another potential result of the trial is that it's possible to achieve and maintain better glycemic or better metabolic control over the time without really needing to increase the number of medications in order to achieve that goal. And we know that type 2 diabetes is a progressive condition often requiring intensification of the treatment.   So these initial results really stand for a great opportunity with tirzepatide. Of course, we need to wait for the 4 years just to confirm that this is indeed the case, but the initial result seems to point along that line. https://www.medpagetoday.com/meetingcoverage/adavideopearls/121967 XX A study from the University of Virginia found that high blood pressure is extremely common among people with diabetes, even among those who believe their blood pressure is under control. Researchers measured blood pressure in 172 adults with type 1 or type 2 diabetes during routine eye clinic visits and found that only 8% had normal readings. About half had stage 2 hypertension, and more than 10% had blood pressure levels high enough to be considered a medical emergency. The study also revealed that many patients were unaware of how serious their blood pressure problems were. Among those who thought their hypertension was well controlled, more than half still had stage 2 hypertension. Nearly 60% of participants were advised to contact their primary care provider, and one patient required an emergency department referral. Most patients supported blood pressure screening during eye exams, leading researchers to suggest that routine blood pressure checks in ophthalmology clinics could help identify undiagnosed or poorly controlled hypertension before it leads to serious complications such as heart attack, stroke, or worsening diabetic eye disease. https://medicalxpress.com/news/2026-06-routine-eye-exams-reveal-stage.html XX What is going on with retatrutide? This is the next generation GLP-1 but it's not authorized outside of clinical trials. Big investigation by CBS shows retatrutide is for sale all over the internet, a phenomenon they say has no modern precedent. CBS News identified more than 120 websites selling or promoting retatrutide, including more than 50 clinics staffed by licensed medical professionals. After being contacted by CBS News, at least 21 clinics abruptly removed retatrutide from their websites or changed the language to state they don't offer it. Others defended prescribing it, saying they're confident enough in results from clinical trials sponsored by drugmaker Eli Lilly that they didn't need to wait for the FDA's independent, rigorous review. An FDA spokesperson said retatrutide "has not been found safe or effective for any condition," adding that it "cannot be manufactured or distributed except for investigational use." The Justice Department is prosecuting two cases – in Utah and Florida – involving the sale and prescription of retatrutide. But the first line of enforcement is often at the state level. Ohio's Board of Pharmacy has taken action against several pharmacies and clinics providing retatrutide, and just last month, Alabama's Medical Board warned physicians against prescribing research-grade medications. The FDA has sent 14 warning letters to companies that have advertised retatrutide since 2024. Of these, at least six have continued to offer it online, including a business called Pink Pony Peptides. A TikTok account associated with the firm responded to the warning in April by taunting the FDA, boasting that the business "just had the best 24 hours ever." In May, Eli Lilly announced that participants in a large clinical trial taking the highest dose of retatrutide lost an average of 28% of their body weight over 80 weeks. Side effects – including nausea, diarrhea, constipation and vomiting – were comparable to similar therapies, the company said. "Anyone purporting to sell retatrutide to consumers is breaking the law," an Eli Lilly spokesperson said https://www.cbsnews.com/projects/2026/experimental-weight-loss-drug/ XX Pioneering research has developed a new way of creating carbohydrate-based medicines, which could ultimately replace costly drugs for common health conditions, using two cheap basic ingredients – table sugar and vinegar. These medications include SGLT2 inhibitors, widely prescribed drugs used to treat type 2 diabetes, heart failure and chronic kidney disease. Co-lead author Professor Phil Baran, Dr. Richard A. Lerner Endowed Chair at Scripps Research, in San Diego, California, said: "The point of this is to show that anyone in a garage can make an SGLT2 inhibitor with reagents that are widely available. We have not patented this method, so we welcome any generic drug company – or anyone else – who wants to use it to help bring costs down for patients." https://www.newswise.com/articles/new-study-shows-table-sugar-could-hold-a-cheaper-quicker-key-to-making-vital-drugs-for-diabetes-heart-failure-and-chronic-kidney-disease XX England and Wales approve teplizumab to slow progression of T1D. At the moment, the Scottish Medicines Consortium does not have an appraisal of Tzield on the go, so, there is likely to be a disparity in access within the UK for the time being. In Northern Ireland, access will depend on a review and adoption of NICE guidance.  Sanofi is expecting to see an uptick in momentum thanks to two subsequent FDA approvals, one in children as young as one with stage 2 T1D, and a second to delay the decline in endogenous insulin production in children aged eight to 17 years recently diagnosed with stage 3 T1D. btw you might here more people referring to stage 4 diabetes. They've added that to include people diagnosed with type 1 who've been on insulin for a longer period of time – basically long enough to not be eligible for the current guidelines for Tzield. https://www.bbc.com/news/articles/ce8mzd94r76oXX XX Obesity Association, a division of the American Diabetes Association® (the association), announced the next section in the Standards of Care in Overweight and Obesity, "Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults," published in Diabetes, Obesity, and CardioMetabolic CARE® and BMJ Open Diabetes Research & Care.  Key highlights of the guidance: Early screening: Annual BMI screening with emphasis on tracking weight trends to identify risk earlier, including a longitudinal life-event weight graph tool for standardized assessment. Enhanced diagnosis: Combines BMI with waist measurements and population-specific thresholds to improve accuracy. Notably, the guidelines recommend that BMI in the overweight range together with central adiposity measurements warrant a formal obesity diagnosis. Comprehensive evaluation: Holistic assessment including medical, behavioral, and social factors. Offers a fully integrated obesity diagnostic algorithm. Risk stratification: Use of tools like the Edmonton Obesity Staging System to guide care. Chronic care approach: Ongoing monitoring and follow-up to support long-term management. Reducing bias: Promotes person-centered, non-stigmatizing care and system-level improvements at the clinical workflow level and encourages screening for prior weight bias/stigma experiences. https://www.prnewswire.com/news-releases/new-standards-of-care-in-overweight-and-obesity-section-screening-diagnosis-evaluation-and-staging-of-obesity-in-adults-302809670.html XX Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience. San Diego-based Dexcom plans to formally begin the new app rollout in July for Apple iPhone and Android users in the U.S. Dexcom said its reimagined app aims to make glucose insights easier to understand and act on. It hopes to help build awareness of how food, activity, sleep and stress influence overall wellbeing.   The company also reiterated plans to launch Stelo internationally. It expects to bring the sensor to the UK, Australia, New Zealand and South Korea later this year, continuing into 2027. https://www.drugdeliverybusiness.com/dexcom-launches-enhanced-stelo-app/ XX MannKind Corporation recently announced it received a grant from Breakthrough T1D to support the INHALE-1 clinical study of Afrezza, its ultra rapid-acting inhaled insulin, in newly diagnosed pediatric type 1 diabetes patients aged 10 to under 18 years. This external funding for a trial focused on early use of Afrezza in children highlights growing third-party support for inhaled insulin in pediatric diabetes care. https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mnkd/mannkind/news/afrezza-pediatric-trial-grant-might-change-the-case-for-inve XX Alexander Zverev heads into Wimbledon with plenty of momentum. The French Open champion returns to the All England Club looking to build on his first Grand Slam title and gain ground on Carlos Alcaraz in the race for the No. 2 spot in the ATP rankings. Zverev has an opportunity to make up points quickly after a first-round exit at Wimbledon last year. But his final tune-up before Wimbledon came with an unexpected challenge. During his semifinal loss to Taylor Fritz at the Halle Open, Zverev said a malfunctioning glucose sensor led to serious diabetes management issues on court. The sensor incorrectly showed his blood sugar was high when it was actually low, causing him to take more insulin than needed. "I had huge problems with the sugar because the sensor I use gave me a completely incorrect reading," Zverev said after the match. "During the match, or rather during the first 45 minutes, I had to consume about 350 grams of sugar. I felt absolutely terrible." Despite feeling unwell, Zverev pushed the match to three sets before falling 6-7(4), 6-4, 7-5 to Fritz. He credited his opponent with playing the better match and said the diabetes-related issue was not an excuse for the result. Zverev, who was diagnosed with type 1 diabetes at age 4, uses Medtronic diabetes technology to help manage his glucose levels while competing on the ATP Tour. He said the sensor error was the first major problem he has experienced after nearly a decade of using the technology. The German said the incident should not affect his Wimbledon preparations. With the sensor issue behind him, Zverev will begin his Wimbledon campaign focused on adding another strong result to what has already been a breakthrough season.   https://www.reuters.com/sports/tennis/zverev-says-glucose-sensor-malfunction-affected-halle-semi-final-loss-fritz-2026-06-21/

Strength training is among the best things you can do to improve your health, and that goes for both adults and children. But what kind of effects does strength training have on children who are overweight or obese? In today's episode, we're discussing a new study review looking into exactly this – and the results are encouraging! *** Do you like what you hear so far? Please leave a five-star review in your podcast player. And hit that follow button! You can also follow us on Instagram. You'll find Daniel at @strengthdan, and Philip at @philipwildenstam. Become a part of our Reddit community here. *** This podcast is brought to you by Styrkelabbet AB, Sweden. To support us, download the world's best gym workout tracker app StrengthLog here. It's completely ad-free and the most generous fitness app on the market, giving you access to unlimited workout logging, lots of workouts and training programs, and much, much more even if you stay a free user for life. If you want a t-shirt with "Train hard, eat well, die anyway", check out our shop here.

In this episode, we sit down with Jade Guerra to discuss hypothyroidism, Type 2 diabetes, and the seven organs that play a critical role in blood sugar regulation. As a chiropractor and nurse practitioner with expertise in functional medicine, Dr. Guerra takes a comprehensive approach to health – helping patients uncover and address the underlying factors that contribute to chronic conditions rather than simply managing symptoms… Drawing from her unique blend of clinical training and holistic wellness strategies, Dr. Guerra works to help individuals improve metabolic health, restore balance, and make sustainable lifestyle changes that support long-term well-being. Hit play to discover: The seven organs involved in regulating blood sugar levels How hypothyroidism and blood sugar imbalances can be interconnected The role of lifestyle and nutrition in supporting metabolic health How reducing toxic exposures may contribute to overall wellness Want to learn more about the root causes of blood sugar dysfunction and thyroid-related health challenges? Join the conversation as Dr. Guerra shares her integrative approach to helping patients achieve better health through nutrition, lifestyle modifications, and personalized care. Connect with Dr. Guerra: Website Instagram YouTube X Tiktok

Nutrition Nugget! Bite-sized bonus episodes offer tips, tricks and approachable science. This week, Jenn is talking about meals on repeat and whether eating the same foods over and over aids in weight loss. A new study claims that less variety in your diet is associated with better results, but is that the full picture? Jenn dives into the research, the numbers, and what they really mean, while questioning whether a 12-week study tells the whole story. Does sticking to the same meals set you up for long-term success, or could it backfire down the road? Tune in to hear Jenn break it all down and find out what she really thinks. Like what you're hearing? Be sure to check out the full-length episodes of new releases every Wednesday. Have an idea for a nutrition nugget? Submit it here: https://asaladwithasideoffries.com/index.php/contact/RESOURCES:Become a Happy Healthy Hub MemberJenn's Free Menu PlanA Salad With a Side of FriesA Salad With A Side Of Fries MerchA Salad With a Side of Fries InstagramKEYWORDS: Jenn Trepeck, Nutrition Nugget, Salad With A Side Of Fries, Health Tips, Wellness Tips, Meals on Repeat, Weight Loss Research, Weight Loss Tips, Weight Loss, Meal Planning, Dietary Repetition, Caloric Stability, Calorie Tracking, Behavioral Weight Loss, MyFitnessPal, Food Logs, Weight Loss Program, Health Psychology, BMI, Overweight, Obesity, Meal Prep, Healthy Eating, Nutrition Tips, Wellness Coach, Diet Routine, Food Variety, Repetitive Meals, Self Control, Weekend Eating Habits, Weekday Eating Habits, Correlation Vs Causation, Diet Studies, Sustainable Weight Loss, Yo Yo Dieting, Healthy Habits, Food Tracking, Calorie Deviation, Diet Boredom, Real Food Coaching, Weight Loss Strategies, Nutrition Myths, Diet Research, Eating Patterns, Salad With A Side Of Fries, Jenn Trepeck, Health Coaching, Body Weight Management, Does Eating The Same Meals Help You Lose Weight, Benefits Of Meal Repetition For Weight Loss

As we enter H2 2026, Manpreet Gill and Ray Heung assess where global markets are heading and what investors should focus on. They outline their reasons for remaining Overweight equities, share their latest views on fixed income and conclude with a discussion on gold. Listen to the full conversation to stay ahead of market shifts.You can read our latest Global Market Outlook today here.Speaker(s):- Manpreet Gill, CIO of Africa, Middle East & Europe (AME/E), Standard Chartered Bank - Ray Heung, Senior Investment Officer,  Standard Chartered Bank For more of our latest market insights, visit Market views on-the-go or subscribe to Standard Chartered Wealth Insights on YouTube.

In this episode, Dr. Thomas Hemingway shares the Truth about Metabolism, what the Data Actually Shows, and it's likely not what you've heard because most people and doctors think our metabolism slows down as we age. The data says differently.  And he explains how you can reverse this and get your metabolism back, running stronger, smoother and cleaner than ever before.  Have a Listen and Share with a Friend!**Free PDF:  "How to Optimize your Metabolism in 7 Easy Steps."   Inside the PDF, we pull back the curtain on how to actually get your metabolism Super-charger and running better than ever before.*And, in my new Performance, and Longevity medical practice we specialize in turning back your biological age and OPTIMIZING HORMONES so you can feel a decade or more younger so you can do the things you want to do that you thought were no longer possible due to your age.  Join the waitlist here!*Don't wait to Prioritize your health, Start Today with the Simple and Powerful Steps detailed in my Best-selling book, PREVENTABLE.*ACCESS my FREE workshop, "GET 10 Years Younger, Stronger, and Sharper"  How to turn back your biological age 10-20 years so you can do the things you want to do that you no longer thought possible due to your age.  Perform at your best and live your best life!Join my Free Masterclass on Midlife Hormones, "Why You Don't Feel like Yourself anymore and What to Do about it!"JET LAG Survival Guide.  Free PDF!*GET DIRECT ACCESS to DR. HEMINGWAY in these AMAZING COURSES!**Free Resource:  "The 7 lab tests your doctor likely is not checking and could be the key to why you don't feel your best." *Don't Forget to SHARE with a Friend and please drop a Review:) It means the world!Mahalo and Aloha andTo your health,

The labor market improving is the crux to the U.S. economy finding its footing, says Ryan Detrick, even though markets showed a lot of negative price action throughout Tuesday's session. He analyzes how it buoys against rising inflation and explains why he's still overweight equities compared to bonds. ======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

More than half of U.S. dogs and cats are overweight or obese—but the reasons go beyond table scraps and too many treats. Dr. Ernie Ward, founder and president of the Association for Pet Obesity Prevention, says the issue is far more complex, and in cats, the link between obesity and diabetes has reached epidemic levels. […]

Binge Eating: She Chose Being Overweight Because She Thought It Would Be Easier [Podcast #696 ] Original copyrighted content published February 19, 2026 at https://fearlessfatloss.com/podcast/binge-eating-she-chose-being-overweight-because-she-thought-it-would-be-easier © 2026-Present JoLynn Braley International LLC

Cara came to me in 2020, thinking she needed to lose weight. She was 52, stuck in survival mode, and convinced her best years were behind her. She'd given up. But what happened over the next six years wasn't about macros or meal plans. It was about rebuilding her identity from the inside out.Today she's 58, leading one of the fastest-growing fitness franchises in the country, and proving that your life doesn't end just because you're not 25 anymore. If you think it's too late for you, this one's gonna hit different.Support the showHosted by Casey Shipp — 3000+ transformations, Self-Made Millionaire, High Priestess, Writer, Fitness Cover Model, and Founder of the Hotbody App.$30M client wins | $7.8M sold onlineRich isn't rare. Category of one is.

Joe Rose shares another wild old-school Dolphins story from the 1980s involving players putting Bengay in a cake as a prank that left a teammate throwing up after taking a bite. The conversation then shifts to current Dolphins OTAs, where running back De'Von Achane is expected to speak to the media following his recent contract extension. Joe reacts strongly to comments from Omar Kelly suggesting Achane showed up to camp looking a little heavy and also sounds off on Omar's previous take that the Dolphins should bring back Christian Wilkins. Plus, the crew briefly revisits whether the Heat could realistically land Giannis Antetokounmpo this offseason.

Hour 3 opens with discussion around reports questioning De'Von Achane's weight as he prepares to speak to the media, with Joe Rose dismissing the concern while also noting similar chatter around Dolphins first-round pick Kenneth Grant. The conversation then shifts to Miami Heat basketball as Ira Winderman joins to break down the Jimmy Butler era, calling him a “diva” at times while still acknowledging his superstar impact, and detailing how Miami could realistically assemble a package for Giannis Antetokounmpo that would likely include multiple prospects and the 13th pick. Winderman also discusses alternative star targets like Ja Morant and Kawhi Leonard, the development of Nikola Jovic and Kel'el Ware, and the stability of the Riley–Spoelstra relationship. The hour closes with NBA Playoffs talk and a broader discussion on some of the ugliest breakups in Miami sports history, including Jimmy Butler, Richie Incognito, Jalen Ramsey, and others.

Legendary Miami Dolphins wide receiver Oronde Gadsden joined the show to share his thoughts on the Dolphins draft picks and his experience of having a weight clause in his contract with the Dolphins.

Are you doing everything right, eating well, exercising, sleeping, and still watching your belly grow and your energy disappear? Or maybe you've heard that menopause changes your metabolism, but nobody's actually explained what that means or what to do about it? Today I talk with Dr. Siobhan Mitchell, one of the leading researchers on mitochondria, metabolism, and women's health. We cover: Why losing estrogen literally rewires how your body uses and stores energy What happens to your gut microbiome as you transition into menopause  What GLP-1 medications are doing to your metabolism and muscle that no one talks about A little-known molecule that is a powerful estrogen mimetic that few have heard of  What actually supports hormonal metabolic health in midlife beyond diet and exercise   Siobhan Mitchell is the chief scientific officer of MitoQ. She completed her PhD at SUNY Albany and a post-doctoral fellowship on brain aging. Siobhan held roles at the three largest food companies in the world (Unilever, Nestle and Pepsico), leading trials in Europe, North America and Asia, which investigated the effects of nutrition on cognitive decline, mood and performance. Additionally she was senior director at Noom, where she directed a team investigating chronic disease management, weight loss and mental health digital programs using cognitive behavior therapy methods. Siobhan has authored over 80 papers, and holds eight patents for aging, cognition and mood products.   Code ZORA for 10% off Hormonal Metabolic Control and other MitoQ products Contact Siobhan Mitchell Email: smitchell@mitoq.com Website: Mitoq.com Instagram: https://instagram.com/mitoq   Give thanks to our sponsors: Try Vitali skincare. 20% off with code ZORA here - https://vitaliskincare.com Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - https://www.oxfordhealthspan.com/ZORA Get Mitopure Urolithin A by Timeline. 20% discount with code ZORA at https://timeline.com/zora Try MitoQ for optimal mitochondrial health. Code ZORA for 20% off https://mitoq.com/zora   Build Strong Bones Masterclass April 25, 2026 https://mailchi.mp/hackmyage/vdrp7df21q Join the Hack My Age community on: YouTube: https://youtube.com/@hackmyage Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠   Biohacking Menopause Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠    For partnership inquiries: https://www.category3.ca/  Some episodes of Hack My Age are supported by partners whose products or services may be discussed during the show. The host may receive compensation or earn a minor commission if you purchase through affiliate links at no extra cost to you. All opinions shared are those of the host and guests, based on personal experience and research, and do not necessarily represent the views of any sponsor. Sponsorships do not imply medical endorsement or approval by any healthcare provider featured on this podcast.

What if your best decade is still ahead of you? At 62, broadcaster and healthy aging expert Liz Earle is fitter, stronger, and happier than ever.In this chat with Fearne, Liz shares how she went from overwhelmed, overweight, and exhausted during perimenopause, to thriving in her 60s. She shares the small lifestyle shifts that transformed her health, and why women in midlife shouldn't feel selfish moving themselves up the priority list.Fearne and Liz dig into the science of aging well, including the power of sunlight (and whether we should be wearing SPF year-round!), and why we should be prioritising sleep and strength training.Plus, what happened when Liz's younger boyfriend took her clubbing for the first time at 60 years old...?Liz's book, How To Age, is out now.Listen to Liz's podcast, Age Better, here!If you liked this episode of Happy Place, you might also like:Naomi WattsCallie BeatonPoorna Bell Hosted on Acast. See acast.com/privacy for more information.

In this episode of The Jordan Syatt Podcast, I speak with Gretchen, an incredible mother of a young boy who she told me is overweight and being bullied.We have a conversation in which I provide insight on what she can do to help him lose weight, improve his health, and increase his confidence.I hope you enjoy this episode and, if you do, please leave a review on iTunes (huge thank you to everyone who has written one so far).Finally, if you've been thinking about joining The Inner Circle but haven't yet... we have hundreds of home and bodyweight workouts for you and you can get them all at https://www.sfinnercircle.com/

Welcome back to our weekend Cabral HouseCall shows!   This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track!   Check out today's questions:    Darem: Hey, Dr Cabral. I recently did a health assessment where everything went well except my practioner telling me I'm overweight according to BMI which was 26.0. She then went off textbookedly (sic) saying to exercise more, eat more fruits & veggies etc. I already do all that for years. I'm 5'6, 161lbs, lean, muscular, 6 pack abs. Around 10% BF. How can I still be overweight      Jenny: Hi Dr. Cabral - I have a question about garlic. In a recent podcast you talked about the many benefits of garlic and of consuming at least a clove a day. Do we get the same great benefits of garlic (including cancer prevention) if it is cooked, roasted, baked as part of a recipe, etc., or does it need to be raw? (I know you talked about smashing it and letting it sit for 5 minutes.) Thank you!      Julie: Hi Dr. Cabral, My daughter (age 3 at the time) was diagnosed with Mycobacterium Avium Complex (MAC). It took awhile to properly diagnose and be treated since it is so rare in children. She was put on multiple medications including antibiotics for about 2 years (ethambutol, rifampin & azithromycin). She is now 9 and doing great, but we recently noticed symptoms of Raynaud's Syndrome. While I am waiting for an endocrinologist appointment I was hoping to see if you had any insight as to what would put her in a compromised state to begin with to be able to contract MAC. And now should I be testing and treating her with protocols to make sure her rain barrel isn't overfilling and if so what do you suggest at this young age?      Tricia: Hi Dr Cabral - hope you and the family are doing well! I have a quick question regarding the GLP Tone and Metavolve systems. I've done both and love them both! I am currently on Metavolve and have been for the last few months. I don't follow the diet plan it comes with strictly, but I do follow your baseline of a Mediterranean diet. I feel really good and am losing weight just more slowly. I'm 56 post-menopausal and am healing on the inside out. My question is can both of these systems be used long term? Are they safe to do so and when I do transition off of Metavolve do I need to do it slowly? Thank you for creating such amazing supplements to assist us in this life long journey of health!      Bob: Hello dr Cabral I wanted to ask for your thoughts on what might cause and what to do with this issue. I normally walk about 10k steps a day and either at mornings or nights have a longer walk about 5 to 6000 and make up the remaining steps throughout the day. But when taking the longer walk I have notice it seems my hands start to swell while walking. I have even noticed it in my wrist as my watch band gets very tight. I don't pump my arms very much when walking and feels harder to make a fist when this happens. Any advise on this for me. It does seem to go back to normal after stopping in few hours      Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions!    - - - Show Notes and Resources: StephenCabral.com/3711 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

Ready to break through your Keto or low-carb plateau? Book a free consultation call with Robert Sikes here: https://www.ketobodybuilding.com/callMost people fail their fitness goals because they live in a state of restriction, not abundance. They believe hours in the gym and endless cardio are the keys to fat loss, but this approach often wrecks metabolism and leads to burnout. In episode 871 of the Savage Perspective Podcast, host Robert Sikes sits down with coach Martin Silva to reveal why building muscle is the true secret to sustainable fat loss and metabolic health. They discuss how to break the cycle of binge eating, why your leanest body isn't your healthiest, and how to build a resilient mindset that guarantees long-term success. This is your guide to building the powerful physique you want without destroying your relationship with food.Get Keto Brick: https://www.ketobrick.com/Subscribe to the podcast: https://open.spotify.com/show/42cjJssghqD01bdWBxRYEg?si=1XYKmPXmR4eKw2O9gGCEuQChapters:0:00 - How Much Muscle REALLY Boosts Your Metabolism1:21 - From Family Tragedy to Fitness Coach: Martin's Origin Story3:02 - Why High-Achievers Neglect Their Health (& How to Fix It)5:08 - The "All-or-Nothing" Trap That Keeps You Unfit7:10 - Do You Actually Need to Spend Hours in the Gym?8:28 - Stop Focusing on The Pebbles: The "Big Rocks" of Fitness9:48 - A Bodybuilder's Confession: My Battle with Binge Eating12:39 - The Vicious Cycle of Punishing Yourself in the Gym14:01 - The Unspoken Truth About Natural Bodybuilding & Health15:59 - Fat Loss vs. Muscle Gain: What Should You Focus On First?17:07 - Why The Mental & Emotional Benefits of Fitness Outweigh The Physical19:39 - Is Tracking Your Food a Necessary Evil for Results?21:30 - Why Carnivore Dieters Stop Seeing Results (And Gain Weight)22:37 - The #1 Most Overlooked Factor for Diet Success23:35 - The Simple Habit-Building Process Most People Ignore25:40 - "When Was The Last Time You Were Consistent for a Full Year?"29:00 - The "Adding, Not Subtracting" Method for Sustainable Fat Loss31:10 - Why You Should Focus on a "Building Phase" (Even if You're Overweight)34:03 - The Truth About How Strength Training Impacts Your Metabolism35:04 - Living in Abundance vs. Scarcity to Fuel Your Body36:30 - How to Shift Your Mindset from Aesthetics to Performance38:12 - Why Your Leanest Physique Isn't Your Healthiest Physique40:15 - Why Muscle Is The Ultimate "Longevity Organ"41:29 - The Biggest Obstacle High-Achieving Clients Face44:08 - The "Never Miss Twice" Rule for Unstoppable Consistency46:40 - The Best Apps for Tracking Fitness & Nutrition48:48 - A Coach's Ideal Body Fat Percentage for Health & Performance50:22 - Is a Full-Body MRI Worth The Investment for Your Health?51:36 - Your Health is The Foundation of All Ambition51:52 - Where to Find More from Martin Silva